{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F12182023-b-51-P5P8L7Iz","width":444,"version":"1.0","type":"rich","title":"12.18.2023 - B 51","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/5c94aef9-cd93-42bb-8db1-1a034232f706\" height=\"200\" width=\"100%\" title=\"12.18.2023 - B 51\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's QuadCast! We highlight results of potentially practice changing B-51, published results of the CURB trial for oligoprogressive lung & breast cancer, what to do with the rare radiation refractory plasmacytoma, and more.\n\n"}